{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:10:17Z","timestamp":1782738617852,"version":"3.54.5"},"reference-count":43,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2022.2547","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T08:34:51Z","timestamp":1652949291000},"source":"Crossref","is-referenced-by-count":2,"title":["Bevacizumab is an effective treatment for symptomatic cerebral necrosis after carbon ion therapy for recurrent intracranial malignant tumours: A case report"],"prefix":"10.3892","volume":"17","author":[{"given":"Ruifeng","family":"Liu","sequence":"first","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Luo","sequence":"additional","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuning","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilong","family":"Sun","sequence":"additional","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Geng","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueshan","family":"Zhao","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"key20220624110037_b1-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"issue":"191","key":"key20220624110037_b2-MCO-17-1-02547","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-017-0930-9","article-title":"Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system","volume":"12","author":"Krauze","year":"2017","journal-title":"Radiat Oncol"},{"key":"key20220624110037_b3-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.21873\/anticanres.11067","article-title":"Re-irradiation for recurrent primary brain tumors","volume":"36","author":"Nieder","year":"2016","journal-title":"Anticancer Res"},{"key":"key20220624110037_b4-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/s0360-3016(98)00544-6","article-title":"Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy","volume":"44","author":"Kanai","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20220624110037_b5-MCO-17-1-02547","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2176\/nmc.ra.2014-0188","article-title":"Pathophysiology, diagnosis, and treatment of radiation necrosis in the brain","volume":"55","author":"Miyatake","year":"2015","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"key20220624110037_b6-MCO-17-1-02547","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ejrnm.2018.03.013","article-title":"Recurrent brain tumor versus radiation necrosis; can dynamic susceptibility contrast (DSC) perfusion magnetic resonance imaging differentiate?","volume":"49","author":"Soliman","year":"2018","journal-title":"Egyptian J Radiol Nuclear Med"},{"key":"key20220624110037_b7-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"273","DOI":"10.14740\/jocmr2936e","article-title":"Bevacizumab for the treatment of radiation-induced cerebral necrosis: A systematic review of the literature","volume":"9","author":"Delishaj","year":"2017","journal-title":"J Clin Med Res"},{"key":"key20220624110037_b8-MCO-17-1-02547","author":"Amin"},{"key":"key20220624110037_b9-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20220624110037_b10-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/cncr.33918","article-title":"Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system","volume":"128","author":"Gritsch","year":"2022","journal-title":"Cancer"},{"key":"key20220624110037_b11-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.3390\/ijms150711832","article-title":"The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence","volume":"15","author":"Parvez","year":"2014","journal-title":"Int J Mol Sci"},{"key":"key20220624110037_b12-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jocn.2012.09.011","article-title":"Cerebral radiation necrosis: A review of the pathobiology, diagnosis and management considerations","volume":"20","author":"Rahmathulla","year":"2013","journal-title":"J Clin Neurosci"},{"issue":"66","key":"key20220624110037_b13-MCO-17-1-02547","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-019-0818-y","article-title":"Cerebral radiation necrosis: incidence, pathogenesis, diagnostic challenges, and future opportunities","volume":"21","author":"Ali","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"key20220624110037_b14-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1088\/1361-6560\/aa6516","article-title":"Experimental dosimetric comparison of 1H, 4He, 12C and 16O scanned ion beams","volume":"62","author":"Tessonnier","year":"2017","journal-title":"Phys Med Biol"},{"key":"key20220624110037_b15-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2010.01.015","article-title":"Proton vs. carbon ion beams in the definitive radiation treatment of cancer patients","volume":"95","author":"Suit","year":"2010","journal-title":"Radiother Oncol"},{"issue":"3022","key":"key20220624110037_b16-MCO-17-1-02547","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12103022","article-title":"Carbon ion radiobiology","volume":"12","author":"Tinganelli","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"135003","key":"key20220624110037_b17-MCO-17-1-02547","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/aaca19","article-title":"An evaluation method of clinical impact with setup, range, and radiosensitivity uncertainties in fractionated carbon-ion therapy","volume":"63","author":"Sakama","year":"2018","journal-title":"Phys Med Biol"},{"key":"key20220624110037_b18-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1088\/0031-9155\/60\/4\/1717","article-title":"Robustness of target dose coverage to motion uncertainties for scanned carbon ion beam tracking therapy of moving tumors","volume":"60","author":"Eley","year":"2015","journal-title":"Phys Med Biol"},{"key":"key20220624110037_b19-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ejmp.2014.04.008","article-title":"Variance-based sensitivity analysis of biological uncertainties in carbon ion therapy","volume":"30","author":"Kamp","year":"2014","journal-title":"Phys Med"},{"key":"key20220624110037_b20-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ijrobp.2009.07.1696","article-title":"Spot scanning proton beam therapy for prostate cancer: Treatment planning technique and analysis of consequences of rotational and translational alignment errors","volume":"78","author":"Meyer","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20220624110037_b21-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1088\/0031-9155\/53\/4\/014","article-title":"Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: The potential effects of calculational uncertainties","volume":"53","author":"Lomax","year":"2008","journal-title":"Phys Med Biol"},{"issue":"82","key":"key20220624110037_b22-MCO-17-1-02547","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00082","article-title":"Carbon ion therapy: A modern review of an emerging technology","volume":"10","author":"Malouff","year":"2020","journal-title":"Front Oncol"},{"key":"key20220624110037_b23-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.apradiso.2015.07.032","article-title":"Localized radiation necrosis model in mouse brain using proton ion beams","volume":"106","author":"Kondo","year":"2015","journal-title":"Appl Radiat Isot"},{"key":"key20220624110037_b24-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2152\/jmi.51.103","article-title":"Experimental model for irradiating a restricted region of the rat brain using heavy-ion beams","volume":"51","author":"Sun","year":"2004","journal-title":"J Med Invest"},{"key":"key20220624110037_b25-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1269\/jrr.43.143","article-title":"Histological and elemental changes in the rat brain after local irradiation with carbon ion beams","volume":"43","author":"Takahashi","year":"2002","journal-title":"J Radiat Res"},{"key":"key20220624110037_b26-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"74","DOI":"10.14338\/IJPT-18-00026.1","article-title":"Particle radiation induced neurotoxicity in the central nervous system","volume":"5","author":"Grosshans","year":"2018","journal-title":"Int J Part Ther"},{"key":"key20220624110037_b27-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.ijrobp.2007.08.015","article-title":"Reirradiation tolerance of the human brain","volume":"70","author":"Mayer","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20220624110037_b28-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11060-011-0610-9","article-title":"The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: Pathological consideration of their potential roles","volume":"105","author":"Nonoguchi","year":"2011","journal-title":"J Neurooncol"},{"issue":"21","key":"key20220624110037_b29-MCO-17-1-02547","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0950-1","article-title":"Bevacizumab treatment for radiation brain necrosis: Mechanism, efficacy and issues","volume":"18","author":"Zhuang","year":"2019","journal-title":"Mol Cancer"},{"key":"key20220624110037_b30-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/0-387-25354-8_2","article-title":"The management of radiation-induced brain injury","volume":"128","author":"Shaw","year":"2006","journal-title":"Cancer Treat Res"},{"key":"key20220624110037_b31-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.ijrobp.2010.11.070","article-title":"Clinical outcomes of 174 nasopharyngeal carcinoma patients with radiation-induced temporal lobe necrosis","volume":"82","author":"Lam","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20220624110037_b32-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.radonc.2019.04.015","article-title":"Comparison between high-dose and low-dose intravenous methylprednisolone therapy in patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma","volume":"137","author":"Zhuo","year":"2019","journal-title":"Radiother Oncol"},{"issue":"167","key":"key20220624110037_b33-MCO-17-1-02547","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-07889-3","article-title":"Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: A systematic review & meta-analysis","volume":"21","author":"Khan","year":"2021","journal-title":"BMC Cancer"},{"key":"key20220624110037_b34-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system","volume":"79","author":"Levin","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20220624110037_b35-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11060-013-1233-0","article-title":"Bevacizumab for radiation necrosis following treatment of high grade glioma: A systematic review of the literature","volume":"115","author":"Lubelski","year":"2013","journal-title":"J Neurooncol"},{"key":"key20220624110037_b36-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11060-014-1391-8","article-title":"An analysis of radiation necrosis of the central nervous system treated with bevacizumab","volume":"117","author":"Tye","year":"2014","journal-title":"J Neurooncol"},{"key":"key20220624110037_b37-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00066-019-01521-x","article-title":"Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: A retrospective monocentric analysis","volume":"196","author":"Bodensohn","year":"2020","journal-title":"Strahlenther Onkol"},{"issue":"25","key":"key20220624110037_b38-MCO-17-1-02547","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783X-17-25","article-title":"Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients","volume":"17","author":"Wang","year":"2012","journal-title":"Eur J Med Res"},{"key":"key20220624110037_b39-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijrobp.2006.10.010","article-title":"Effect of bevacizumab on radiation necrosis of the brain","volume":"67","author":"Gonzalez","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20220624110037_b40-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/jjco\/hys231","article-title":"Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET","volume":"43","author":"Furuse","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"key20220624110037_b41-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1634\/theoncologist.2012-0068","article-title":"Overcoming resistance to antiangiogenic therapies","volume":"17","author":"Tejpar","year":"2012","journal-title":"Oncologist"},{"key":"key20220624110037_b42-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10456-014-9420-y","article-title":"Anti-angiogenic therapy for cancer: Current progress, unresolved questions and future directions","volume":"17","author":"Vasudev","year":"2014","journal-title":"Angiogenesis"},{"key":"key20220624110037_b43-MCO-17-1-02547","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1200\/JCO.2010.31.4815","article-title":"Exacerbation of cerebral radiation necrosis by bevacizumab","volume":"29","author":"Jeyaretna","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T08:00:44Z","timestamp":1656057644000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2022.2547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,5,19]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2022.2547","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"article-number":"114"}}